Package 48102-028-35

{"route": ["OPHTHALMIC"], "spl_id": "8b20bece-92d7-4715-aad0-6eddba900c2c", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0348102028356"], "unii": ["X4HES1O11F"], "rxcui": ["199413", "2734142"], "spl_set_id": ["3ce26231-bc40-48b0-85e5-2e7622f334d7"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Fera Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (48102-028-35)  / 3.5 g in 1 TUBE", "package_ndc": "48102-028-35", "marketing_start_date": "20260131"}], "brand_name": "Avaclyr", "product_id": "48102-028_8b20bece-92d7-4715-aad0-6eddba900c2c", "dosage_form": "OINTMENT", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "48102-028", "generic_name": "ACYCLOVIR", "labeler_name": "Fera Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Avaclyr", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "30 mg/g"}], "application_number": "NDA202408", "marketing_category": "NDA", "marketing_start_date": "20260131", "listing_expiration_date": "20271231"}